The roughly 17 million Americans who received Johnson & Johnson’s COVID-19 vaccine have been advised for more than a year that it is the least effective vaccine offered in the U.S., but new data suggests that may not be the case, The New York Times reported March 15.
Read the full post on Becker's Hospital Review - Healthcare News
